Loading clinical trials...
Loading clinical trials...
Explore the effectiveness and safety of tailored hydration guided by lung water index monitor system for prevention of acute kidney injury after percutaneous coronary intervention for elderly patients...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Chinese PLA General Hospital
NCT06474169 · Chronic Kidney Diseases
NCT07660419 · Coronary Artery Disease (CAD), Coronary Stenosis
NCT06779630 · Coronary Artery Disease
NCT05830942 · Cognitive Dysfunction, Mobility Limitation, and more
NCT07194590 · Chronic Kidney Disease (Stage 3-4), Vascular Function, and more
Chinese PLA general hospital
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions